endocrine global landing Page

Pfizer is proud to introduce 2017 Global ASPIRE Young Investigator Research Awards in Endocrinology

As competition for research funding opportunities increases, the ASPIRE program underscores Pfizer's commitment to supporting promising young investigators with an interest in advancing their academic research careers in Endocrinology.

Mission

The mission of the 2017 Global ASPIRE Young Investigator Research Awards in Endocrinology is to advance the medical knowledge of the fundamental mechanisms of disease, mechanisms of action of current and potential future treatments, and to improve the care of patients with endocrine disorders.

The ASPIRE Program demonstrates Pfizer’s commitment to supporting promising young investigators with an interest in advancing knowledge in defined disease areas of endocrinology.

Background

Scientific research continues to advance our knowledge and understanding of endocrine disorders and their treatments. The 2017 Global ASPIRE Young Investigator Research Awards in Endocrinology is designed to:

  1. Support young investigators working in the field of endocrinology.
  2. Advance the understanding of disease mechanisms or treatments through translational basic science or clinical research in order to enhance the clinical care of pediatric and young adult patients with endocrine diseases.

Request for Proposals and Areas of Focus

Pfizer invites junior investigators to apply for the 2017 Global ASPIRE Young Investigator Research Awards in Endocrinology. Funding will be provided to research proposals that seek to explore translational or clinical research in the area of endocrine disease in children and young adults to address:

  1. Morbidity and mortality in Adult Growth Hormone Deficiency or Acromegaly
  2. Impact and/or needs of the patient with Growth Disorders during the pediatric and transitional years/young adult life
  3. Novel strategies including Quality of Life and Patient Reported Outcomes to evaluate and treat acromegaly or Adult Growth Hormone Deficiency.
  4. Early diagnosis and treatment of Adult Growth Hormone Deficiency or Acromegaly

Available Awards

Pfizer is funding 5 awards of up to $50,000 USD each for one year to conduct basic science, translational or clinical research generating data that will help advance the science of endocrine diseases in children and young adults.